Furthermore, this study indicated that CTCF mutations were enriched in tumor samples of metastatic BC compared to local BC (2% vs. 0.9%, P < 0.01), and it was supposed that CTCF mutation might be a metastatic driver [45]. Here, CTCF is linked to breast cancer.